eFlow Rapid nebuliser for the treatment of patients with cystic fibrosis
HTA - Health Technology Assessment Report
Details- 2010
- Mundy L, Hiller JE
Effectiveness of recombinant human Growth Hormone (rhGH) in the treatment of patients with cystic fibrosis.
HTA - Health Technology Assessment Report
Details- 2010
- Phung OJ
Is neonatal screening for cystic fibrosis recommended in Belgium?
HTA - Health Technology Assessment Report
Details- 2010
- Proesmans M
Hypertonic saline nebules for patients with cystic fibrosis and bronchioectasis: a review of the clinical and cost-effectiveness
HTA - Health Technology Assessment Report
Details- 2009
- Brown A
Communication of carrier status information following universal newborn screening for sickle cell disorders and cystic fibrosis: qualitative study of experience and practice
HTA - Health Technology Assessment Report
Details- 2009
- Kai J
- 2009
- Medical Advisory Secretariat
Denufosol for cystic fibrosis with mild lung disease
HTA - Health Technology Assessment Report
Details- 2009
- National Horizon Scanning Centre
Colistimethate sodium powder for inhalation (Colobreathe) for pseudomonas aeruginosa lung infection in cystic fibrosis
HTA - Health Technology Assessment Report
Details- 2009
- National Horizon Scanning Centre
- 2009
- Purins A, Hiller JE
An Early Health Economic Analysis of the Potential Cost Effectiveness of an Adherence Intervention to Improve Outcomes for Patients with Cystic Fibrosis.
NHSEED - Economic Study or Review
Details- 2017
- Tappenden P